Tatar, E. Et Al. 2016. The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , vol.71, no.4 , 221-226.

Tatar, E., Mirili, C., Isikyakar, T., Yaprak, M., Guvercin, G., Ozay, E., ... Asci, G.(2016). The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , vol.71, no.4, 221-226.

Tatar, Erhan Et Al. "The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease," Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , vol.71, no.4, 221-226, 2016

Tatar, Erhan Et Al. "The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease." Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , vol.71, no.4, pp.221-226, 2016

Tatar, E. Et Al. (2016) . "The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease." Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , vol.71, no.4, pp.221-226.

@article{article, author={Erhan Tatar Et Al. }, title={The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease}, journal={Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine}, year=2016, pages={221-226} }